Isoclean® Pharmacy Compounding Aseptic Containment Isolator (Recirculating)

Isoclean® Pharmacy Compounding Aseptic Containment Isolator (Recirculating)
by Esco Technologies Inc


Esco Isoclean Pharmacy Compounding Aseptic Containment Isolator (Recirculating), provides a safe and clean environment for compounding of hazardous, sterile drug preparations in compliance with USP 797* criteria. Barrier isolation system provides inherently superior sterility compared to open front clean air devices such as laminar flow clean benches and Class II biological safety cabinets. US...read more

Request Pricing




Receive your quote directly from Esco Technologies Inc for Isoclean® Pharmacy Compounding Aseptic Containment Isolator (Recirculating)

Description

 

Esco Isoclean Pharmacy Compounding Aseptic Containment Isolator (Recirculating), provides a safe and clean environment for compounding of hazardous, sterile drug preparations in compliance with USP 797* criteria.

Barrier isolation system provides inherently superior sterility compared to open front clean air devices such as laminar flow clean benches and Class II biological safety cabinets. USP797 guidelines specify that isolators may be situated in an area subject to less severe environmental controls compared with open front clean air devices.

When used as part of a system that includes operator aseptic technique training, process validation, expiration setting, product quality maintenance after the CSP leaves the pharmacy, isolators are a cost-effective solution especially for lower-volume pharmacies. They reduce operating and renovation costs, take up less space, and are easier to maintain.

The Isoclean Compounding Aseptic Containment Isolator (Recirculating) is suitable for work involving hazardous materials, antineoplastic, or cytotoxic compounding applications. The work zone and pass-thru interchange are under negative pressure to the room in order to maintain operator protection in case of a breach in the barrier isolation system.

* United States Pharmacopoeia (USP), Chapter 797(1), enacted January 1, 2004, presents the first enforceable standards for sterile compounding. Following years of patient safety recommendations and professional guidelines, the intent of USP 797 is to set forth the procedural and practical requirements for safe compounding of sterile preparations. The Chapter's requirements are applicable in all practice settings where sterile preparations are compounded.

Product Overview

Isoclean® Pharmacy Compounding Aseptic Containment Isolator (Recirculating) by Esco Technologies Inc
Isoclean® Pharmacy Compounding Aseptic Containment Isolator (Recirculating)

SelectScience Trusted Banner

Why make an inquiry with SelectScience?

Advertisement

Advertisement